{"id":3529,"date":"2025-09-05T16:35:09","date_gmt":"2025-09-05T07:35:09","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/member_search\/3529"},"modified":"2025-09-05T16:35:09","modified_gmt":"2025-09-05T07:35:09","slug":"%e8%b0%b7%e7%94%b0%e9%83%a8%e3%80%80%e6%81%ad","status":"publish","type":"researcher","link":"https:\/\/atlas.ncc.go.jp\/en\/member_search\/3529","title":{"rendered":"Yasushi Yatabe EN"},"template":"","class_list":["post-3529","researcher","type-researcher","status-publish","hentry","en-US"],"acf":{"name_eg":"Yasushi Yatabe","familyName_eg":"Yatabe","has_jp_name":true,"name_jp":"\u8c37\u7530\u90e8\u3000\u606d","researcher_photo":897,"participated_in":["1"],"degree":"MD, PhD","position":"Chief, Dept of Diagnostic Pathology\/ Chief, Div. of Molecular Pathology","eg_position":"Chief, Dept of Diagnostic Pathology\/ Chief, Div. of Molecular Pathology","facilities":3399,"department":["33"],"speciality":"","eg_speciality":"","background":"<h2>Dr. YATABE Yasushi's Story<\/h2>\r\n<p>My carier started as a hematopathologist, spent a post-doc for studying stem cells of colorectal cancer and currently focusing on thoracic tumors using a molecular pathology approach. As a diagnostic pathologist, I am aiming for new diagnosis incorporating molecular biology.<\/p>\r\n<h2>Research Interest<\/h2>\r\n<p>Thracic malignancies (lung cancer, thymoma and mesothelioma), biomarker, translational research<\/p>\r\n<h2>Speciality Field<\/h2>\r\n<p>Anatomic and molecular pathology, Thoracic Oncology<\/p>\r\n<h2>Qualifications<\/h2>\r\n<p>Diagnostic Pathologist (Japanese Society of Pathology, July, 1996)<br \/>\r\nClinical Cytologic Diagnosis (Japanese Society of Clinical Cytology, December 1996)<\/p>\r\n<h2>Professional Experience<\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 58px;\">\r\n<tbody>\r\n<tr style=\"height: 10px;\">\r\n<td style=\"width: 16.9284%; height: 10px;\">2015 and 2021<\/td>\r\n<td style=\"width: 50%; height: 10px;\">Chapter editor, the WHO classification of tumors of lung, pleura, thymus and heart.<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 16.9284%; height: 24px;\">2015 to 2017<\/td>\r\n<td style=\"width: 50%; height: 24px;\">Past Chair, Pathology Panel, International Association for the Study of Lung Cancer.<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 16.9284%; height: 24px;\">2015 to 2017<\/td>\r\n<td style=\"width: 50%; height: 24px;\">Past co chair, for CAP\/IASLC\/AMP molecular testing guidelines.<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2><br \/>\r\n<br \/>\r\n<\/h2>","eg_background":"<h2>Dr. YATABE Yasushi's Story<\/h2>\r\n<p>My carier started as a hematopathologist, spent a post-doc for studying stem cells of colorectal cancer and currently focusing on thoracic tumors using a molecular pathology approach. As a diagnostic pathologist, I am aiming for new diagnosis incorporating molecular biology.<\/p>\r\n<h2>Research Interest<\/h2>\r\n<p>Thracic malignancies (lung cancer, thymoma and mesothelioma), biomarker, translational research<\/p>\r\n<h2>Speciality Field<\/h2>\r\n<p>Anatomic and molecular pathology, Thoracic Oncology<\/p>\r\n<h2>Qualifications<\/h2>\r\n<p>Diagnostic Pathologist (Japanese Society of Pathology, July, 1996)<br \/>\r\nClinical Cytologic Diagnosis (Japanese Society of Clinical Cytology, December 1996)<\/p>\r\n<h2>Professional Experience<\/h2>\r\n<table style=\"border-collapse: collapse; width: 100%; height: 58px;\">\r\n<tbody>\r\n<tr style=\"height: 10px;\">\r\n<td style=\"width: 16.9284%; height: 10px;\">2015 and 2021<\/td>\r\n<td style=\"width: 50%; height: 10px;\">Chapter editor, the WHO classification of tumors of lung, pleura, thymus and heart.<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 16.9284%; height: 24px;\">2015 to 2017<\/td>\r\n<td style=\"width: 50%; height: 24px;\">Past Chair, Pathology Panel, International Association for the Study of Lung Cancer.<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 16.9284%; height: 24px;\">2015 to 2017<\/td>\r\n<td style=\"width: 50%; height: 24px;\">Past co chair, for CAP\/IASLC\/AMP molecular testing guidelines.<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>","researcher_outerlink1":"","researcher_outerlink2":"","researcher_outerlink3":"","researcher_outerlink4":"","researcher_outerlink5":"","is_retired":false},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher\/3529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/researcher"}],"acf:post":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/facility\/3399"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}